3.21
+0.18(+5.94%)
Currency In USD
| Previous Close | 3.03 |
| Open | 3.09 |
| Day High | 3.21 |
| Day Low | 2.99 |
| 52-Week High | 4.87 |
| 52-Week Low | 0 |
| Volume | 400 |
| Average Volume | 1,724 |
| Market Cap | 41.69M |
| PE | 3.96 |
| EPS | 0.81 |
| Moving Average 50 Days | 3.29 |
| Moving Average 200 Days | 1.81 |
| Change | 0.18 |
If you invested $1000 in Eagle Pharmaceuticals, Inc. (EGRX) 10 years ago, it would be worth $39.69 as of September 09, 2025 at a share price of $3.21. Whereas If you bought $1000 worth of Eagle Pharmaceuticals, Inc. (EGRX) shares 5 years ago, it would be worth $86.06 as of September 09, 2025 at a share price of $3.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
GlobeNewswire Inc.
Aug 28, 2025 11:30 PM GMT
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subj
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
GlobeNewswire Inc.
Aug 18, 2025 8:30 PM GMT
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) will be held on October 17, 2025
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
GlobeNewswire Inc.
Mar 31, 2025 8:00 PM GMT
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement with an entity that was provided capital by funds